Publikationen, an denen er mitarbeitet MARIA JESUS SANZ FERRANDO (22)

2021

  1. Role of antiangiogenic VEGF-A165b in angiogenesis and systolic function after reperfused myocardial infarction

    Revista Espanola de Cardiologia, Vol. 74, Núm. 2, pp. 131-139

2018

  1. Coronary Serum Obtained After Myocardial Infarction Induces Angiogenesis and Microvascular Obstruction Repair. Role of Hypoxia-inducible Factor-1A

    Revista Espanola de Cardiologia, Vol. 71, Núm. 6, pp. 440-449

2017

  1. Dynamics and implications of circulating anti-angiogenic VEGF-A165b isoform in patients with ST-elevation myocardial infarction

    Scientific Reports, Vol. 7, Núm. 1

2013

  1. Arterial and venous endothelia display differential functional fractalkine (CX3CL1) expression by angiotensin-ii

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 33, Núm. 1, pp. 96-104

  2. Critical role of fractalkine (CX3CL1) in cigarette smoke-induced mononuclear cell adhesion to the arterial endothelium

    Thorax, Vol. 68, Núm. 2, pp. 177-186

2012

  1. Synthesis and reactive oxygen species scavenging activity of halogenated alkaloids from boldine

    Medicinal Chemistry Research, Vol. 21, Núm. 10, pp. 3133-3139

2010

  1. Trans- but not cis-resveratrol impairs angiotensin-II-mediated vascular inflammation through inhibition of NF-κB activation and peroxisome proliferator-activated receptor-γ upregulation

    Journal of Immunology, Vol. 185, Núm. 6, pp. 3718-3727

2009

  1. Menopause and ovariectomy cause a low grade of systemic inflammation that may be prevented by chronic treatment with low doses of estrogen or losartan

    Journal of Immunology, Vol. 183, Núm. 2, pp. 1393-1402

2007

  1. A critical role for TNFα in the selective attachment of mononuclear leukocytes to angiotensin-II-stimulated arterioles

    Blood, Vol. 110, Núm. 6, pp. 1895-1902

  2. CXCR2 blockade impairs angiotensin II-induced CC chemokine synthesis and mononuclear leukocyte infiltration

    Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 27, Núm. 11, pp. 2370-2376

  3. Roflumilast inhibits leukocyte-endothelial cell interactions, expression of adhesion molecules and microvascular permeability

    British Journal of Pharmacology, Vol. 152, Núm. 4, pp. 481-492

2006

  1. Angiotensin II-induced mononuclear leukocyte interactions with arteriolar and venular endothelium are mediated by the release of different CC chemokines

    Journal of Immunology, Vol. 176, Núm. 9, pp. 5577-5586

  2. Olive oil-based lipid emulsion's neutral effects on neutrophil functions and leukocyte-endothelial cell interactions

    Journal of Parenteral and Enteral Nutrition, Vol. 30, Núm. 4, pp. 286-296

2005

  1. Effect of boldine, secoboldine, and boldine methine on angiotensin II-induced neurtrophil recruitment in vivo

    Journal of Leukocyte Biology, Vol. 78, Núm. 3, pp. 696-704

  2. Erythromycin exerts in vivo anti-inflammatory activity downregulating cell adhesion molecule expression

    British Journal of Pharmacology, Vol. 144, Núm. 2, pp. 190-201

  3. L-NAME induces direct arteriolar leukocytes adhesion, which is mainly mediated by angiotensin-II

    Microcirculation, Vol. 12, Núm. 5, pp. 443-453

2004

  1. Angiotensin II induces neutrophil accumulation in vivo through generation and release of CXC chemokines

    Circulation, Vol. 110, Núm. 23, pp. 3581-3586

  2. Direct evidence of leukocyte adhesion in arterioles by angiotensin II

    Blood, Vol. 104, Núm. 2, pp. 402-408

  3. Erratum: Effect of two phenanthrene alkaloids on angiotensin II-induced leukocyte-endothelial cell interactions in vivo (British Journal of Pharmacology (2003) 140 (1057-1067) DOI: 10.1038/sj.bjp.0705525))

    British Journal of Pharmacology

  4. Reactive oxygen species (ROS) generation inhibited by aporphine and phenanthrene alkaloids semi-synthesized from natural boldine

    Chemical and Pharmaceutical Bulletin, Vol. 52, Núm. 6, pp. 696-699